Reported Standalone quarterly numbers for Remedium Lifecare are:
Net Sales at Rs 81.57 crore in March 2025 down 94.21% from Rs. 1,408.49 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 2.64 crore in March 2025 up 95.08% from Rs. 53.72 crore in March 2024.
EBITDA stands negative at Rs. 0.52 crore in March 2025 up 98.38% from Rs. 32.14 crore in March 2024.
Remedium Lifeca shares closed at 0.88 on June 23, 2025 (BSE) and has given -75.76% returns over the last 6 months and -92.48% over the last 12 months.
Story continues below Advertisement
| Remedium Lifecare | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 81.57 | 38.15 | 1,408.49 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 81.57 | 38.15 | 1,408.49 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | 8.98 | 77.70 | 1,422.31 | | Increase/Decrease in Stocks | 71.66 | -37.27 | 19.31 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.09 | 0.20 | 0.18 | | Depreciation | 0.01 | 0.01 | 0.01 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 2.01 | 2.99 | 1.72 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -1.19 | -5.49 | -35.04 | | Other Income | 0.66 | 7.43 | 2.89 | | P/L Before Int., Excpt. Items & Tax | -0.53 | 1.94 | -32.15 | | Interest | 1.59 | 0.88 | 3.85 | | P/L Before Exceptional Items & Tax | -2.12 | 1.06 | -36.00 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -2.12 | 1.06 | -36.00 | | Tax | 0.52 | 0.29 | 17.72 | | P/L After Tax from Ordinary Activities | -2.64 | 0.76 | -53.72 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -2.64 | 0.76 | -53.72 | | Equity Share Capital | 40.32 | 40.32 | 10.08 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.07 | 0.02 | -149.22 | | Diluted EPS | -0.07 | 0.02 | -149.22 | | EPS After Extra Ordinary | | Basic EPS | -0.07 | 0.02 | -149.22 | | Diluted EPS | -0.07 | 0.02 | -149.22 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
